Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
IRAK4 INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2017/024589
Kind Code:
A1
Abstract:
The present invention relates to a compound inhibiting the activity of an IRAK4 kinase, a pharmaceutical composition thereof, a use thereof in preparing drugs, a method in which same is used for inhibiting the activity of the IRAK4 kinase and a method in which same is used for treating and/or preventing IRAK4 kinase mediated diseases or conditions in mammals (particularly humans). The compound has a structural formula I.

More Like This:
WO/2003/0828541-N-AMINOBENZIMIDAZOLE DERIVATIVES
JP20045258952-Heteroaryl-3,4-dihydro-2H-pyrrole derivative and its use as a pest control agent
WO/2023/030319OPIOID RECEPTOR AGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Inventors:
LIU JINMING (CN)
SU HENG (CN)
MA TAO (CN)
CHA MI YOUNG (CN)
Application Number:
PCT/CN2015/086894
Publication Date:
February 16, 2017
Filing Date:
August 13, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BEIJING HANMI PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D495/04; A61K31/519; A61K31/5377; A61P1/04; A61P7/02; A61P19/02; A61P35/00; A61P37/00
Foreign References:
JP2008013527A2008-01-24
CN103442568A2013-12-11
Other References:
See also references of EP 3336091A4
Attorney, Agent or Firm:
BEIJING INTELLEGAL INTELLECTUAL PROPERTY AGENT LTD. (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: SERVICE PROCESSING METHOD AND APPARATUS

Next Patent: WIRELESS COMMUNICATION METHOD, ENODB AND USER EQUIPMENT